Table 4.
Prognosis of patients in the two groups
|
Project
|
GTG
|
ITG
|
χ2
|
P value
|
| Renal endpoint | 14 | 7 | ||
| Serious infection | 4 | 2 | ||
| Serious liver injury | 4 | 2 | ||
| Serious complication | 10 | 8 | ||
| Incidence of endpoint events | 32% | 19% | 4.448 | 0.035 |
| Follow-up time (mo) | 10.11 ± 3.09 | 11.07 ± 2.08 | 2.000 | 0.048 |
GTG: Glucocorticoid therapy group; ITG: Immunosuppressive therapy group.